Clinical Trial Update: Pharmacologic Relapse Prevention for Alcoholic Smokers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on a pharmacologic relapse-prevention strategy for individuals with alcoholism who smoke. The Mayo Clinic-sponsored study has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Tobacco Use Disorder

Snippet

Sponsor: Mayo Clinic | Conditions: Alcoholism, Smoking | Phase 2 | Status: COMPLETED